Sumitomo Dainippon Pharma has announced a 700 million yen ($6 million) investment in a company that aims to enhance the functionality of cyborg technologies and 17 October 2018
In a special report piece, Ed Corbett, principal at specialist pharmaceutical strategy consultants, Novasecta, considers an issue of paramount importance to the 3 October 2018
A cloud-based informatics platform being launched by US pharma giant Merck & Co and Accenture has been launched with the claim that it will improve productivity 20 September 2018
Supply chain imperatives are evolving from drug production and delivery that are limited in scope towards a versatile supply chain addressing the needs of multi 17 September 2018
Making patients the owners of and beneficiaries from their own data will be key to making blockchain technology deliver for healthcare as a whole, according to 22 August 2018
“The Russian pharma market is like a huge ocean. If you know who lives in the ocean and what sort of currents the ocean has, then it is all simple and understan 10 August 2018
Sanofi Ventures, the investment arm of French pharma major Sanofi has entered into a $17 million deal with New York-based Click Therapeutics. 23 July 2018
For several years, pharma analysts have predicted varying degrees of impact from nascent blockchain technologies. While some anticipate wholesale revolution, ot 23 July 2018
Christopher Bouton is the founder and CEO of Vyasa, a provider of deep learning software for the life sciences and healthcare industries. In our latest look at 9 May 2018
Akili Interactive, a prescription digital medicine company developing novel treatments for cognitive dysfunction that was founded by London-listed biopharma com 9 May 2018
Ian Churcher is VP for drug discovery at Benevolent and a former GSK director and University of Oxford professor. Writing exclusively for The Pharma Letter, he 27 April 2018
The rising cost of drug development, growing need for medicines with an aging population and the greater prevalence of chronic conditions, political uncertainty 24 April 2018
Mindful that integrating model-informed drug development (MIDD) into more drug applications and advancing its use are US Food and Drug Administration’s (FDA) go 20 April 2018
Business, technical, and financial incentives are driving the rapid adoption of cloud-based, commercially available solutions in pharmaceutical research and ope 27 March 2018
Deals with tech companies are almost seen as essential in pharma today as they consider how to combat challenges such as rising development costs, but rarely is 26 March 2018
Harnessing digital technologies could unlock £22 billion ($30.1 billion) for UK pharma companies over the next decade, according to Accenture. 13 March 2018
In the second of two Expert View columns to whet the appetite for the eyeforpharma Barcelona event in March, Sanofi’s Chief Data Officer (CDO), Milind Kamkolkar 31 January 2018
In a highly informative and useful Expert View piece.Heather Longden.senior marketing manager for informatics regulatory compliance at the analytical laboratory 26 January 2018
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.